GO:0015871 choline transport: genes and methods

Choline transport (GO:0015871) is the biological process by which choline, an essential amino alcohol, is moved across cellular membranes by dedicated transporters or pores. Choline is a precursor for phosphatidylcholine, sphingomyelin, and acetylcholine, and it contributes methyl groups to one-carbon metabolism; therefore, its uptake and distribution are fundamental to membrane integrity, neurotransmission, and methylation reactions. The QuickGO definition captures this process as the directed movement of choline into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Research over the past two decades has identified several distinct choline transport systems with different affinities, tissue distributions, and subcellular localizations. The high-affinity choline transporter SLC5A7 (CHT1) is responsible for presynaptic choline uptake in cholinergic neurons and is rate-limiting for acetylcholine synthesis. The choline transporter-like protein 1 (SLC44A1/CTL1) contributes to choline uptake for phospholipid synthesis in many cell types. More recently, FLVCR1 and FLVCR2 were identified as plasma-membrane and brain choline transporters, respectively, and SLC25A48 was shown to control mitochondrial choline import. MFSD7B also facilitates choline transport, and its missense mutations affect transport function. Because choline transport sits at the intersection of lipid metabolism, neurotransmission, and mitochondrial one-carbon metabolism, it is a compelling area for functional genomics. Researchers use CRISPR-based knockout, point-mutation, knock-in, and overexpression models to determine which transporters are causally involved in choline uptake under specific physiological and pathological conditions. This article summarizes the ontology, molecular mechanisms, key genes, disease links, and research methods for GO:0015871, with all factual claims supported by the verified literature listed below.

GO:0015871 choline transport is defined by QuickGO as the directed movement of choline into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. Choline (2-hydroxyethyltrimethylammonium) is an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine. In practice, this term covers the activity of membrane proteins that recognize choline and translocate it across lipid bilayers, including plasma-membrane uptake systems, mitochondrial importers, and intracellular transport steps.

Choline transport is essential because choline cannot be synthesized de novo in sufficient amounts by all human cells and must be acquired from the extracellular environment or mobilized between compartments. The process supplies substrate for phosphatidylcholine synthesis, which is required for membrane biogenesis and lipoprotein secretion, and for acetylcholine production in cholinergic neurons. In addition, mitochondrial choline import via SLC25A48 feeds one-carbon metabolism and supports nucleotide synthesis and redox balance. Defects in choline transporters have been linked to neurological disease, developmental abnormalities, and cancer, making GO:0015871 a high-value target for mechanistic and translational research.

The following genes encode proteins that directly mediate or regulate choline transport (GO:0015871) and are supported by the verified literature.

Choline transport is regulated at multiple levels to match cellular demand for phospholipid synthesis, acetylcholine production, and mitochondrial one-carbon metabolism. The expression and activity of SLC44A1 (CTL1) and SLC5A7 (CHT1) are modulated in response to developmental and metabolic cues, and CHT1-mediated uptake is rate-limiting for acetylcholine synthesis. Mitochondrial choline import by SLC25A48 is responsive to one-carbon metabolic needs, linking choline transport to nucleotide synthesis and redox balance. Disease-associated mutations in FLVCR1, FLVCR2, and MFSD7B can disrupt these regulatory relationships, leading to impaired choline transport and downstream metabolic consequences. The molecular mechanisms of choline and ethanolamine transport also provide a structural framework for understanding how regulation is achieved at the transporter level.

FLVCR2 mediates choline uptake into the brain, and its structural and molecular basis has been characterized, linking brain choline transport to neurological function. FLVCR1 was identified as a plasma-membrane choline transporter in mammals through integrative genetic analysis, and its dysfunction is associated with neurodegenerative phenotypes. CHT1-mediated high-affinity choline uptake is rate-limiting for acetylcholine synthesis, so impaired choline transport can contribute to cholinergic dysfunction in neurodegenerative conditions.

MFSD7B facilitates choline transport, and missense mutations in MFSD7B affect choline transport function, suggesting that transporter variants can cause or modify developmental and metabolic disorders. Mutations in FLVCR1 and FLVCR2 have been linked to developmental and neurological phenotypes, reinforcing the importance of choline transport in normal development.

Choline transport for phospholipid synthesis supports membrane biogenesis and cell proliferation, processes that are upregulated in cancer cells. SLC44A1 (CTL1) has an emerging role in choline transport for phospholipid synthesis, and its activity can influence tumor cell growth. Targeting choline transport pathways is therefore of interest for cancer metabolism research.

SLC25A48 controls mitochondrial choline import and metabolism, connecting choline transport to one-carbon metabolism, nucleotide synthesis, and redox balance. Dysregulation of this mitochondrial transport step could contribute to metabolic disorders and cancer.

Direct measurement of choline transport is performed using radiolabeled or fluorescent choline analogs in cultured cells. These assays quantify uptake kinetics and are used to compare wild-type and mutant transporters, as demonstrated for CHT1, FLVCR1, FLVCR2, MFSD7B, and SLC25A48.

Structural studies of choline transporters such as CHT1 and FLVCR2 have revealed the molecular basis of substrate recognition and translocation. The molecular mechanism of choline and ethanolamine transport in humans has also been characterized structurally, providing a framework for understanding transporter function.

CRISPR knockout, point-mutation, knock-in, and overexpression models are used to test the causal role of choline transporter genes. Integrative genetic analysis identified FLVCR1 as a plasma-membrane choline transporter, and SLC25A48 was shown to control mitochondrial choline import using such approaches.

Metabolomics and lipidomics measure downstream effects of choline transport, including phosphatidylcholine synthesis and one-carbon metabolites. SLC25A48 loss alters mitochondrial choline metabolism, and CTL1 activity influences phospholipid synthesis.

Researchers studying choline transport-related genes often need to determine whether a candidate gene is causally involved in choline uptake, phospholipid synthesis, acetylcholine production, or mitochondrial one-carbon metabolism. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly, using knockout, point-mutation, knock-in, and overexpression strategies supported by the literature on GO:0015871.

GO:0015871 choline transport is a fundamental biological process that supplies choline for membrane phospholipid synthesis, acetylcholine production, and mitochondrial one-carbon metabolism. The identification of multiple transporters, including SLC5A7, SLC44A1, FLVCR1, FLVCR2, MFSD7B, and SLC25A48, has revealed a complex and compartmentalized transport system with direct links to neurological, developmental, and metabolic disease. CRISPR-based functional genomics provides a powerful approach to dissect the causal roles of these transporters and their disease-associated variants. By combining knockout, point-mutation, knock-in, and overexpression models with uptake assays, metabolomics, and structural studies, researchers can advance the understanding of choline transport in health and disease.